Trial Profile
Duration of maintenance anti-psychotic therapy after first -episode schizophrenia: a double-blind randomized placebo-control relapse prevention study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 17 Dec 2007 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2006 New trial record.